HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Pegaptanib was effective and safe without a dose-response relation in neovascular, age-related, macular degeneration.

AuthorsFrank Sullivan
JournalACP journal club (ACP J Club) 2005 Jul-Aug Vol. 143 Issue 1 Pg. 18 ISSN: 1056-8751 [Print] United States
PMID15989306 (Publication Type: Comment, Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: